Health Canada drug identification number

DIN 02520788 — TRODELVY 180 MG

TRODELVY is a powder for solution of Sacituzumab govitecan marketed by GILEAD SCIENCES CANADA INC. The full Sacituzumab govitecan monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02520788
Brand name
TRODELVY
Active ingredient
Sacituzumab govitecan
Strength
180 MG
Dosage form
POWDER FOR SOLUTION
Route
INTRAVENOUS
Manufacturer
GILEAD SCIENCES CANADA INC
Health Canada status
MARKETED
Drug class
Antibody-drug conjugate (Trop-2-directed antineoplastic)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.